Multidisciplinary Centers Take Up Challenges

Research universities and federal funding agencies are taking a new approach to cutting-edge research in life sciences: multidisciplinary teams of scientists. Already in 1999, two Ivy League universities have announced plans for new institutes that will bring together physical and biological scientists to tackle problems. Other major universities have embarked on similar initiatives within the past year. And a research institute that will open a campus in the Midwest next year plans to carry ou

Written byPeter Gwynne
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Research universities and federal funding agencies are taking a new approach to cutting-edge research in life sciences: multidisciplinary teams of scientists. Already in 1999, two Ivy League universities have announced plans for new institutes that will bring together physical and biological scientists to tackle problems. Other major universities have embarked on similar initiatives within the past year. And a research institute that will open a campus in the Midwest next year plans to carry out multidisciplinary medical research.

"There's a growing recognition that the time is ripe for physical science and engineering to come together with biological and medical sciences," says Steven Chu, a Nobel laureate who is professor of applied physics at Stanford University. "Biology has become very data-rich. You want to develop ways of analyzing the data."

Multidisciplinary research in the life sciences "is indeed a general trend," agrees James Edwards, deputy assistant director of biological sciences at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies